Literature DB >> 10921986

Use of 5-bromo-4-chloro-3-indolyl-alpha-D-N-acetylneuraminic acid in a novel spot test To identify sialidase activity in vaginal swabs from women with bacterial vaginosis.

R Wiggins1, T Crowley, P J Horner, P W Soothill, M R Millar, A P Corfield.   

Abstract

The validity of measuring vaginal sialidase activity to identify bacterial vaginosis (BV) was determined by using 5-bromo-4-chloro-3-indolyl-alpha-D-N-acetylneuraminic acid in a near-patient test. The sensitivity and specificity of the test for prediction of BV were 95.6 and 96.3%, respectively. Positive and negative predictive values were 95.6 and 96.3%, respectively. This test may be an alternative to Gram staining.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921986      PMCID: PMC87196     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Mucinase and sialidase activity of the vaginal microflora: implications for the pathogenesis of preterm labour.

Authors:  L Howe; R Wiggins; P W Soothill; M R Millar; P J Horner; A P Corfield
Journal:  Int J STD AIDS       Date:  1999-07       Impact factor: 1.359

Review 2.  A review of premature birth and subclinical infection.

Authors:  R S Gibbs; R Romero; S L Hillier; D A Eschenbach; R L Sweet
Journal:  Am J Obstet Gynecol       Date:  1992-05       Impact factor: 8.661

3.  Vaginal microflora associated with bacterial vaginosis in Japanese and Thai pregnant women.

Authors:  S Puapermpoonsiri; N Kato; K Watanabe; K Ueno; C Chongsomchai; P Lumbiganon
Journal:  Clin Infect Dis       Date:  1996-10       Impact factor: 9.079

4.  Immunoglobulin A response against Gardnerella vaginalis hemolysin and sialidase activity in bacterial vaginosis.

Authors:  S Cauci; S Driussi; R Monte; P Lanzafame; E Pitzus; F Quadrifoglio
Journal:  Am J Obstet Gynecol       Date:  1998-03       Impact factor: 8.661

5.  A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity.

Authors:  S L Hillier; J Martius; M Krohn; N Kiviat; K K Holmes; D A Eschenbach
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

6.  Diagnosis of bacterial vaginosis in a gynaecology clinic.

Authors:  P E Hay; D Taylor-Robinson; R F Lamont
Journal:  Br J Obstet Gynaecol       Date:  1992-01

7.  Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream.

Authors:  J A McGregor; J I French; W Jones; K Milligan; P J McKinney; E Patterson; R Parker
Journal:  Am J Obstet Gynecol       Date:  1994-04       Impact factor: 8.661

8.  Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Vaginal Infections and Prematurity Study Group.

Authors:  S L Hillier; M A Krohn; R P Nugent; R S Gibbs
Journal:  Am J Obstet Gynecol       Date:  1992-03       Impact factor: 8.661

9.  Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid.

Authors:  C A Spiegel; R Amsel; K K Holmes
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

10.  The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor.

Authors:  D H Watts; M A Krohn; S L Hillier; D A Eschenbach
Journal:  Obstet Gynecol       Date:  1992-03       Impact factor: 7.661

View more
  16 in total

Review 1.  Mucinases and sialidases: their role in the pathogenesis of sexually transmitted infections in the female genital tract.

Authors:  R Wiggins; S J Hicks; P W Soothill; M R Millar; A P Corfield
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

2.  Testing for sexually transmitted infections: a brave new world?

Authors:  R W Peeling
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

3.  A novel bacterial mucinase, glycosulfatase, is associated with bacterial vaginosis.

Authors:  Anthony M Roberton; Rebecca Wiggins; Patrick J Horner; Rosemary Greenwood; Theresa Crowley; Arnold Fernandes; Monica Berry; Anthony P Corfield
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Identification and characterization of NanH2 and NanH3, enzymes responsible for sialidase activity in the vaginal bacterium Gardnerella vaginalis.

Authors:  Lloyd S Robinson; Jane Schwebke; Warren G Lewis; Amanda L Lewis
Journal:  J Biol Chem       Date:  2019-02-05       Impact factor: 5.157

5.  Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis.

Authors:  C S Bradshaw; A N Morton; S M Garland; L B Horvath; I Kuzevska; C K Fairley
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

6.  BVBlue test for diagnosis of bacterial vaginosis.

Authors:  Linda Myziuk; Barbara Romanowski; Stephen C Johnson
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  Degradation, foraging, and depletion of mucus sialoglycans by the vagina-adapted Actinobacterium Gardnerella vaginalis.

Authors:  Warren G Lewis; Lloyd S Robinson; Nicole M Gilbert; Justin C Perry; Amanda L Lewis
Journal:  J Biol Chem       Date:  2013-03-11       Impact factor: 5.157

8.  Rapid tests for sexually transmitted diseases.

Authors:  Charlotte Ann Gaydos
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.725

9.  Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential.

Authors:  Carl J Yeoman; Suleyman Yildirim; Susan M Thomas; A Scott Durkin; Manolito Torralba; Granger Sutton; Christian J Buhay; Yan Ding; Shannon P Dugan-Rocha; Donna M Muzny; Xiang Qin; Richard A Gibbs; Steven R Leigh; Rebecca Stumpf; Bryan A White; Sarah K Highlander; Karen E Nelson; Brenda A Wilson
Journal:  PLoS One       Date:  2010-08-26       Impact factor: 3.240

10.  Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis.

Authors:  Nicole M Gilbert; Warren G Lewis; Amanda L Lewis
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.